Results 131 to 140 of about 8,248,666 (375)

VALUE AT RISK - CORPORATE RISK MEASUREMENT [PDF]

The notion of "risk" is used in a number of sciences. The Faculty of Law studies the risk depending on its legality. The Accident Theory applies this term to describe the damage and the disasters.
Anis Cecilia-Nicoleta, Apolzan (Angyal) Carmen-Maria, Roth Anne-Marie   +2 more
core  

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

The Predictive Value of Risk Factors and Prognostic Scores in Hospitalized COVID-19 Patients. [PDF]

Diagnostics (Basel), 2023
Brajkovic M, Vukcevic M, Nikolic S, Dukic M, Brankovic M, Sekulic A, Popadic V, Stjepanovic M, Radojevic A, Markovic-Denic L, Rajovic N, Milic N, Tanasilovic S, Todorovic Z, Zdravkovic M.   +14 more
europepmc   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

Molecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath, Irene A. George, Srikanth S. Manda, Prasanth Ariyannur, Ekta R. Dhawale, Raja Sekhar Kommu, Rajan Datar, Darshana Patil, Vinita Trivedi, Manisha Singh, Kumar Prabhash, Sewanti Limaye, Richa Chauhan, Prashant Kumar   +13 more
wiley   +1 more source

Value at Risk

, 2018
Die vorliegende Arbeit befasst sich mit dem Thema Bayesscher Zugang zum Value at Risk. Mit diesem Maß sollen Risiken bezüglich verschiedener Investitionen vergleichbar werden und Vorhersagen für Verluste getroffen werden können. Der Aufbau dieser Niederschrift wurde chronologisch so gestaltet, dass die einzelnen Schritte logisch nachvollziehbar ...
openaire   +3 more sources

Implied value-at-risk and model-free simulation. [PDF]

Ann Oper Res, 2022
Bernard C, Perchiazzo A, Vanduffel S.
europepmc   +1 more source

A Two-stage Inexact Programming with Value-at-risk under Uncertainty

, 2022
Xiangming Kong, Donglin Wang, Jing Zhao, Rong Cheng   +3 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

GARCHNet: Value-at-Risk Forecasting with GARCH Models Based on Neural Networks. [PDF]

Comput Econ, 2023
Buczynski M, Chlebus M.
europepmc   +1 more source

Testing, Comparing, and Combining Value at Risk Measures [PDF]

Value-at-Risk (VaR) has emerged as the standard tool for measuring and reporting financial market risk. Currently, more than eighty commercial vendors offer enterprise or trading risk management systems which report VaR-like measures.
Atsushi Inoue, Jinyong Hahn, Peter Christoffersen   +2 more
core